Company News, Financial News

Q2 Financials: Johnson & Johnson

Company highlights Neutrogena's performance in international skin health/beauty as a driver of growth.

Author Image

By: Christine Esposito

Editor-in-Chief

Johnson & Johnson, maker of Neutrogena and Aveeno skincare, has released results for the second quarter of 2022. Worldwide corporate revenues in Q2 rose 3.0% to  $24.0 billion. J&J’s worldwide consumer health business sales fell 1.3% to $3.8 billion. However, sales rose 2.3% operationally when factoring in the impact of translational currency, said J&J.  Major contributors to growth included upper respiratory and analgesic products in the international market and in digestiv...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters